Oppenheimer & Co’s Nu Skin NUS Stock Holding History

Oppenheimer & Co’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-1,610	Closed	-$223K	–	1450
2013 Q4	$223K	Buy	+1,610	New	+$190K	0.01%	1165

Other funds holding NUS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ESG

Emerging Sovereign Group New York $252M AUM 22.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

PGP

Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

FIM

Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return

VVP

Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return

Oppenheimer & Co's NUS Position: Q1 2014 in Review

Oppenheimer & Co sold out of Nu Skin (NUS) in Q1 2014, closing a stake of 1,610 shares — an estimated $223K sold.

Oppenheimer & Co first reported a position in NUS in Q4 2013 and held it in 1 quarter. The position peaked at $223K in Q4 2013. 289 funds tracked by Wall St. Rank hold NUS as of Q1 2014.

Oppenheimer & Co reported no remaining Nu Skin position as of Q1 2014 after selling out during the quarter.
Oppenheimer & Co sold 1,610 Nu Skin shares in Q1 2014, an estimated $223K.
Oppenheimer & Co first reported a position in Nu Skin in Q4 2013 and held it in 1 quarter.
Oppenheimer & Co's Nu Skin position peaked at $223K in Q4 2013.
289 funds tracked by Wall St. Rank held Nu Skin as of Q1 2014.

Based on Oppenheimer & Co's 13F filing for Q1 2014, filed 9 May 2014.